Home SVCC Area: English - Español - Português
Clopidogrel and Aspirin Versus Ticlopidine
and Aspirin After the Placement of
Coronary Artery Stents
Pedroni, P.; Giachello, F.; Iravedra, J.;
Säger, F.; García Casassa, R.
Hospital Italiano de La Plata y Clínica 25 de Mayo Mar del Plata,
Cátedra libre de postgrado en Cardiología, Universidad Nacional de
La Plata, Buenos Aires, Argentina
Objective: To compare the safety and efficacy of clopidogrel (c) and aspirin vs. ticlopidine (t) and aspirin after the placement of elective coronary artery stents.
Methods: 97 patients (p) with severe coronary artery disease were included; exclusion criteria were previous anticoagulation, GP IIb IIIa administration, unsuccessful procedure, residual stenosis > ó = 50% and urgent target vassel revascularization. T y C were administred 48 hs. before and 25 days after the procedure, 250 mgr twice and 75 mgr once a day, respectively.
Clinical evaluation, platelet and haematologic counts were done at 25 th days. All data are show in the following .
A p value < ó = 0.05 was considered statistically significant.
Conclusions: Antiplatelet therapy with aspirin and clopidogrel seems to be comparably safe and effective as aspirin and ticlopidine after the placement of coronary artery stents.
2nd Virtual Congress of Cardiology
Dr. Florencio Garófalo
Dr. Raúl Bretal
Dr. Armando Pacher
Technical Committee - CETIFAC
Copyright© 1999-2001 Argentine Federation of Cardiology
All rights reserved
This company contributed to the Congress: